In the first half of the year, sales at Nanofocus fell by 32 percent to 3.65 million euros. The EBITDA improves from -0.15 million euros to -0.12 million euros. The loss comes to EUR 0.64 million (previous year: EUR -0.62 million). The equity ratio drops from 31.7 percent to 24 percent. The liquid funds amount to EUR 0.66 million (previous year: EUR 0.89 million). The pandemic has an impact on business and thus also on the numbers of Oberhausen residents.
The sales situation improved slightly in the third quarter. But there is still no planning security for Nanofocus. A 15 percent decline in sales is expected for 2020. EBITDA is expected to be negative.
Michael Hauptmannl, sole director of Nanofocus, looks to the future: “NanFocus now has lean structures and can work profitably with annual sales of around 10 million euros. Achieving this level of sales in a normal market environment is realistic. But for that we need financial leeway. Because the economic uncertainties and restrictions due to the Covid-19 pandemic will be with us for even longer. “
An extraordinary general meeting is planned at Nanofocus on November 5th. A capital reduction is to be decided there. After that, a resolution will be adopted on a capital increase with subscription rights for the shareholders. Since the shares of Nanofocus are currently 0.33 euros, a normal capital increase cannot be carried out.